《新股表現》科倫博泰生物(06990.HK)暗盤高開0.7報61元
根據輝立交易平台顯示,明天掛牌的科倫博泰生物-B(06990.HK)暗盤高開0.7%報61元,高低見61.5元/60.65元,現報61元,較上市價60.6元,高0.7%,成交2.8萬股。
默沙東任第二大股東的科倫博泰是一家創新生物醫藥公司,致力於腫瘤學、免疫學及其他治療領域的創新藥物的研發、製造及商業化。
是次在港上市共發售2,244.61萬股H股,並已引入包括母企科倫藥業(002422.SZ)旗下科倫國際、RTW Funds、Laurion Capital Master Fun、TruMed,以及東方證券(03958.HK)及中國東航集團有份投資的匯添富五名基石投資者,合共認購867.7萬股;10%公開發售獲0.27倍超購,認購一手中籤率75%;股份以招股範圍(60.6-72.8元)下限定價,料集資淨額約12.59億元,其中約45%用於核心產品SKB264及A166研發和商業化,約30%用於其他主要產品研發及商業化,約12%用於技術平台持續開發、推進其他現有管線資產及探索開發新候選藥物。上市聯席保薦人分別為高盛及中信証券。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.